NCT00898794|Unknown
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer
Influence of Bevacizumab and VEGF on Platelet Aggregation
Loading search results
Influence of Bevacizumab and VEGF on Platelet Aggregation
Sponsor study identifier
Secondary identifiers
REGISTRY · PDQ (Physician Data Query)
observational
20
1 country
1
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedRATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about the effect of bevacizumab and VEGF on platelet clustering. PURPOSE: This research study is looking at the effect of bevacizumab and VEGF on platelet clustering in patients with cancer who are receiving bevacizumab.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
May 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 9, 2009
Actual (reported)May 12, 2009
Actual (reported)Influence of bevacizumab on platelet aggregation
Influence of VEGF on platelet aggregation
Influence of VEGF or bevacizumab on cyclooxygenesis
Correlation between medication sequence and platelet aggregation
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Kantonsspital Graubuenden
Chur, CH-7000, Switzerland
Roger von Moos, MD
Kantonsspital Graubünden
First Submitted
May 9, 2009
First Posted
May 12, 2009
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Last Updated
August 7, 2013
Record last verified: 2011-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: